UC suppressed the expression of the AKT/mTOR signaling pathway in CRC cells, and YBX1 overexpression greatly reversed the expression of AKT/mTOR signaling pathway when treated with UC (Fig. 5F). This evidence concerns the gene YBX1 and colorectal carcinoma.